DNMT3A regulates murine megakaryocyte-biased hematopoietic stem cell fate decisions
Sarah Waldvogel(Baylor College of Medicine), Margaret A. Goodell(Baylor College of Medicine), Chun-Wei Chen(Baylor College of Medicine), Alan R. Burns(University of Houston), Kellie R. Machlus(Brigham and Women's Hospital), Dandan Fan(Zhejiang Lab), Jaime M. Reyes(Dana-Farber Cancer Institute), Elmira Khabusheva(Baylor College of Medicine), Rachel E. Rau(Baylor College of Medicine), Estelle Carminita(Boston Children's Hospital), Virginia Camacho(Boston Children's Hospital), Benjamin Deneen(Baylor College of Medicine), Jianzhong Su(Zhejiang Lab), Joanne I. Hsu(Harvard University), María N. Barrachina(Boston Children's Hospital), Rolando E. Rumbaut(Michael E. DeBakey VA Medical Center), Anna Guzman(Baylor College of Medicine), Jacey R. Pridgen(Baylor College of Medicine), Ashlyn Laidman(Baylor College of Medicine), Josephine De La Fuente(Baylor College of Medicine), Subhashree Pradhan(Michael E. DeBakey VA Medical Center), Justin Courson(Michael E. DeBakey VA Medical Center), Alejandra Garcia-Martell(Baylor College of Medicine), Michael R. Williamson(Baylor College of Medicine)
Cited by 1
Related Papers
The incredible journey: From megakaryocyte development to platelet formation
|The Journal of Cell Biology|2013|833
PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy
|Cell stem cell|2018|423
Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9
|Cell Reports|2016|283
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands
|Nature Chemical Biology|2018|229